GABA A Receptor Subtypes: Therapeutic Potential in Down Syndrome, Affective Disorders, Schizophrenia, and Autism

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391 · see citing works

Neuronal Oscillations in Cortical Networks

Buzsáki, G., & Draguhn, A. (2004) · Science · doi:10.1126/science.1099745 · Cited by 6,576 · see citing works

Mechanisms of Gamma Oscillations

Buzsáki, G., & Wang, X.-J. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150444 · Cited by 2,796 · see citing works

Model of autism: increased ratio of excitation/inhibition in key neural systems

Rubenstein, J. L. R., & Merzenich, M. M. (2003) · Genes, Brain and Behavior · doi:10.1034/j.1601-183x.2003.00037.x · Cited by 2,768 · see citing works

Neocortical excitation/inhibition balance in information processing and social dysfunction

Yizhar, O., Fenno, L. E., Prigge, M., Schneider, F., Davidson, T. J., O’Shea, D. J., Sohal, V. S., Goshen, I., Finkelstein, J., Paz, J. T., et al. (2011) · Nature · doi:10.1038/nature10360 · Cited by 2,454 · see citing works

Cortical inhibitory neurons and schizophrenia

Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297 · see citing works

Neuronal Diversity and Temporal Dynamics: The Unity of Hippocampal Circuit Operations

Klausberger, T., & Somogyi, P. (2008) · Science · doi:10.1126/science.1149381 · Cited by 2,050 · see citing works

Animal models of neuropsychiatric disorders

Nestler, E. J., & Hyman, S. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2647 · Cited by 2,023 · see citing works

Updated national birth prevalence estimates for selected birth defects in the United States, 2004–2006

Parker, S. E., Mai, C. T., Canfield, M. A., Rickard, R., Wang, Y., Meyer, R. E., Anderson, P., Mason, C. A., Collins, J. S., Kirby, R. S., et al. (2010) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20735 · Cited by 1,887 · see citing works

Time-Dependent Processes in Memory Storage: Recent studies of learning and memory indicate that memory storage involves time-dependent processes.

McGaugh, J. L. (1966) · Science · doi:10.1126/science.153.3742.1351 · Cited by 1,468 · see citing works

Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy

Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292 · see citing works

The amygdala

LeDoux, J. (2007) · Current Biology · doi:10.1016/j.cub.2007.08.005 · Cited by 1,281 · see citing works

Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes

Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H. (1999) · Nature · doi:10.1038/44579 · Cited by 1,172 · see citing works

Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes

Chao, H.-T., Chen, H., Samaco, R. C., Xue, M., Chahrour, M., Yoo, J., Neul, J. L., Gong, S., Lu, H.-C., Heintz, N., et al. (2010) · Nature · doi:10.1038/nature09582 · Cited by 1,168 · see citing works

Neurosteroids: endogenous regulators of the GABAA receptor

Belelli, D., & Lambert, J. J. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1703 · Cited by 1,159 · see citing works

Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits

Peñagarikano, O., Abrahams, B. S., Herman, E. I., Winden, K. D., Gdalyahu, A., Dong, H., Sonnenblick, L. I., Gruver, R., Almajano, J., Bragin, A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.040 · Cited by 1,075 · see citing works

Molecular mechanisms of fear learning and memory

Johansen, J. P., Cain, C. K., Ostroff, L. E., & LeDoux, J. E. (2011) · Cell · doi:10.1016/j.cell.2011.10.009 · Cited by 1,012 · see citing works

Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic

Ressler, K. J., & Mayberg, H. S. (2007) · Nature Neuroscience · doi:10.1038/nn1944 · Cited by 1,007 · see citing works

Neurocognitive mechanisms of anxiety: An integrative account

Bishop, S. J. (2007) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2007.05.008 · Cited by 976 · see citing works

Molecular and neuronal substrate for the selective attenuation of anxiety

Löw, K., Crestani, F., Keist, R., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Rülicke, T., Bluethmann, H., Möhler, H., et al. (2000) · Science · doi:10.1126/science.290.5489.131 · Cited by 946 · see citing works

Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype

McKernan, R. M., Rosahl, T. W., Reynolds, D. S., Sur, C., Wafford, K. A., Atack, J. R., Farrar, S., Myers, J., Cook, G., Ferris, P., et al. (2000) · Nature Neuroscience · doi:10.1038/75761 · Cited by 944 · see citing works

The GABAergic deficit hypothesis of major depressive disorder

Luscher, B., Shen, Q., & Sahir, N. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.120 · Cited by 934 · see citing works

Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders

Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T. C., Fan, J., Akula, N., Groyer, G., Adams, D., & Schumacher, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3295 · Cited by 930 · see citing works

Amygdala inhibitory circuits and the control of fear memory

Ehrlich, I., Humeau, Y., Grenier, F., Ciocchi, S., Herry, C., & Lüthi, A. (2009) · Neuron · doi:10.1016/j.neuron.2009.05.026 · Cited by 878 · see citing works

Genetic dissection of an amygdala microcircuit that gates conditioned fear

Haubensak, W., Kunwar, P. S., Cai, H., Ciocchi, S., Wall, N. R., Ponnusamy, R., Biag, J., Dong, H.-W., Deisseroth, K., Callaway, E. M., et al. (2010) · Nature · doi:10.1038/nature09553 · Cited by 840 · cited 1× · see citing works

Subtype-Specific Alterations of γ-Aminobutyric Acid and Glutamatein Patients With Major Depression

Sanacora, G., Gueorguieva, R. V., Epperson, C. N., Wu, Y., Appel, M., Rothman, D. L., Krystal, J. H., & Mason, G. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.705 · Cited by 796 · see citing works

Molecular and neuronal substrates for general anaesthetics

Rudolph, U., & Antkowiak, B. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1496 · Cited by 771 · see citing works

Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes

Rudolph, U., & Knoflach, F. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3502 · Cited by 733 · cited 1× · see citing works

Extrasynaptic GABAA Receptors: Their Function in the CNS and Implications for Disease

Brickley, S. G., & Módy, I. (2012) · Neuron · doi:10.1016/j.neuron.2011.12.012 · Cited by 674 · see citing works

Autistic-like behaviour in Scn1a+/− mice and rescue by enhanced GABA-mediated neurotransmission

Han, S., Tai, C., Westenbroek, R. E., Yu, F. H., Cheah, C. S., Potter, G. B., Rubenstein, J. L., Scheuer, T., de la Iglesia, H. O., & Catterall, W. A. (2012) · Nature · doi:10.1038/nature11356 · Cited by 643 · see citing works

Enhanced Learning and Memory and Altered GABAergic Synaptic Transmission in Mice Lacking the α5 Subunit of the GABA _A Receptor

Collinson, N., Kuenzi, F. M., Jarolimek, W., Maubach, K. A., Cothliff, R., Sur, C., Smith, A., Otu, F. M., Howell, O., Atack, J. R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-13-05572.2002 · Cited by 628 · see citing works

Reduced Cortical γ-Aminobutyric Acid Levels in Depressed Patients Determined by Proton Magnetic Resonance Spectroscopy

Sanacora, G., Mason, G. F., Rothman, D. L., Behar, K. L., Hyder, F., Petroff, O. A. C., Berman, R. M., Charney, D. S., & Krystal, J. H. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.11.1043 · Cited by 627 · see citing works

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

Baldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T., den Boer, J. A., Fineberg, N. A., Knapp, M., Scott, J., et al. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105059253 · Cited by 617 · see citing works

Common circuit defect of excitatory-inhibitory balance in mouse models of autism

Gogolla, N., LeBlanc, J. J., Quast, K. B., Südhof, T. C., Fagiolini, M., & Hensch, T. K. (2009) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-009-9023-x · Cited by 610 · see citing works

Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues

Crestani, F., Lorez, M., Baer, K., Essrich, C., Benke, D., Laurent, J. P., Belzung, C., Fritschy, J.-M., Lüscher, B., & Mohler, H. (1999) · Nature Neuroscience · doi:10.1038/12207 · Cited by 550 · see citing works

Neural computations associated with goal-directed choice

Rangel, A., & Hare, T. (2010) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.03.001 · Cited by 532 · see citing works

Trace fear conditioning involves hippocampal α ₅ GABA _A receptors

Crestani, F., Keist, R., Fritschy, J.-M., Benke, D., Vogt, K., Prut, L., Blüthmann, H., Möhler, H., & Rudolph, U. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142288699 · Cited by 528 · see citing works

Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome

Fernandez, F., Morishita, W., Zuniga, E., Nguyen, J., Blank, M., Malenka, R. C., & Garner, C. C. (2007) · Nature Neuroscience · doi:10.1038/nn1860 · Cited by 509 · see citing works

GABA-based therapeutic approaches: GABAA receptor subtype functions

RUDOLPH, U., & MOHLER, H. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.10.003 · Cited by 499 · see citing works

Cognitive deficits and associated neurological complications in individuals with Down's syndrome

Lott, I. T., & Dierssen, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70112-5 · Cited by 484 · see citing works

Neuronal circuits of fear extinction

Herry, C., Ferraguti, F., Singewald, N., Letzkus, J. J., Ehrlich, I., & Lüthi, A. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07101.x · Cited by 484 · see citing works

Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder

Fava, M., McCall, W. V., Krystal, A., Wessel, T., Rubens, R., Caron, J., Amato, D., & Roth, T. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.01.016 · Cited by 480 · see citing works

Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome

Kleschevnikov, A. M., Belichenko, P. V., Villar, A. J., Epstein, C. J., Malenka, R. C., & Mobley, W. C. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1766-04.2004 · Cited by 459 · see citing works

Stuck in a rut: rethinking depression and its treatment

Holtzheimer, P. E., & Mayberg, H. S. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.10.004 · Cited by 431 · see citing works

Benzodiazepine-insensitive mice generated by targeted disruption of the gamma 2 subunit gene of gamma-aminobutyric acid type A receptors.

Günther, U., Benson, J. A., Benke, D., Fritschy, J., Reyes, G., Knoflach, F., Crestani, F., Aguzzi, A., Arigoni, M., Lang, Y., et al. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7749 · Cited by 423 · see citing works

Neural bases for addictive properties of benzodiazepines

Tan, K. R., Brown, M., Labouèbe, G., Yvon, C., Creton, C., Fritschy, J.-M., Rudolph, U., & Lüscher, C. (2010) · Nature · doi:10.1038/nature08758 · Cited by 397 · see citing works

Which GABA _A Receptor Subunits Are Necessary for Tonic Inhibition in the Hippocampus?

Glykys, J., Mann, E. O., & Mody, I. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4751-07.2008 · Cited by 370 · see citing works

Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation

Carlezon, W. A., & Chartoff, E. H. (2007) · Nature Protocols · doi:10.1038/nprot.2007.441 · Cited by 368 · see citing works

Activation of GABAA Receptors: Views from Outside the Synaptic Cleft

Glykys, J., & Mody, I. (2007) · Neuron · doi:10.1016/j.neuron.2007.11.002 · Cited by 358 · see citing works

Consolidation and Reconsolidation: Two Lives of Memories?

McKenzie, S., & Eichenbaum, H. (2011) · Neuron · doi:10.1016/j.neuron.2011.06.037 · Cited by 338 · see citing works

Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects

Rupprecht, R., Rammes, G., Eser, D., Baghai, T. C., Schüle, C., Nothdurfter, C., Troxler, T., Gentsch, C., Kalkman, H. O., Chaperon, F., et al. (2009) · Science · doi:10.1126/science.1175055 · Cited by 328 · see citing works

Formation and plasticity of GABAergic synapses: physiological mechanisms and pathophysiological implications

Fritschy, J., & Brünig, I. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00037-8 · Cited by 322 · see citing works

The understanding of the brain

Eccles, J. C. (1973) · DigitalGeorgetown (Georgetown University Library) · Cited by 315 · see citing works

Subunit-Selective Modulation of GABA Type A Receptor Neurotransmission and Cognition in Schizophrenia

Lewis, D. A., Cho, R. Y., Carter, C. S., Eklund, K. E., Förster, S., Kelly, M. A., & Montrose, D. M. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08030395 · Cited by 286 · see citing works

Localized microstimulation of primate pregenual cingulate cortex induces negative decision-making

Amemori, K.-I., & Graybiel, A. M. (2012) · Nature Neuroscience · doi:10.1038/nn.3088 · Cited by 262 · see citing works

GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon

Guidotti, A., Auta, J., Davis, J. M., Dong, E., Grayson, D. R., Veldic, M., Zhang, X., & Costa, E. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2212-8 · Cited by 262 · see citing works

The 50th anniversary of the discovery of trisomy 21: The past, present, and future of research and treatment of Down syndrome

Mégarbané, A., Ravel, A., Mircher, C., Sturtz, F. G., Grattau, Y., Rethoré, M. O., Delabar, J. M., & Mobley, W. C. (2009) · Genetics in Medicine · doi:10.1097/gim.0b013e3181b2e34c · Cited by 261 · see citing works

Olig1 and Olig2 triplication causes developmental brain defects in down syndrome.

Chakrabarti, L., Best, T. K., Cramer, N. P., Carney, R. S. E., Isaac, J. T. R., Galdzicki, Z., & Haydar, T. F. (2010) · Nature Neuroscience · doi:10.1038/nn.2600 · Cited by 258 · see citing works

Evidence for a Significant Role of α3-Containing GABA_AReceptors in Mediating the Anxiolytic Effects of Benzodiazepines

Dias, R., Sheppard, W. F. A., Fradley, R. L., Garrett, E. M., Stanley, J. L., Tye, S. J., Goodacre, S., Lincoln, R. J., Cook, S. M., Conley, R., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1166-05.2005 · Cited by 247 · see citing works

α5GABA A Receptors Mediate the Amnestic But Not Sedative-Hypnotic Effects of the General Anesthetic Etomidate

Cheng, V., Martin, L. J., Elliott, E. M., Kim, J. H., Mount, H. T. J., Taverna, F. A., Roder, J., MacDonald, J. F., Bhambri, A., Collinson, N., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.5024-05.2006 · Cited by 246 · see citing works

An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition

Dawson, G. R., Maubach, K. A., Collinson, N., Cobain, M., Everitt, B. J., MacLeod, A. M., Choudhury, H. I., McDonald, L. M., Pillai, G., Rycroft, W., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.092320 · Cited by 241 · see citing works

Reduced Evoked Gamma Oscillations in the Frontal Cortex in Schizophrenia Patients: A TMS/EEG Study

Ferrarelli, F., Massimini, M., Peterson, M. J., Riedner, B. A., Lazar, M., Murphy, M. J., Huber, R., Rosanova, M., Alexander, A. L., Kalin, N. H., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07111733 · Cited by 233 · see citing works

Altered long-term potentiation in the young and old Ts65Dn mouse, a model for down syndrome

Siarey, R. J., Stoll, J., Rapoport, S. I., & Galdzicki, Z. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00157-3 · Cited by 222 · see citing works

Control of hippocampal gamma oscillation frequency by tonic inhibition and excitation of interneurons

Mann, E. O., & Mody, I. (2010) · Nature Neuroscience · doi:10.1038/nn.2464 · Cited by 222 · see citing works

Hippocampal Network Hyperactivity After Selective Reduction of Tonic Inhibition in GABAA Receptor α5 Subunit–Deficient Mice

Glykys, J. C., & Módy, I. (2006) · Journal of Neurophysiology · doi:10.1152/jn.01122.2005 · Cited by 216 · see citing works

GABAergic Control of Adult Hippocampal Neurogenesis in Relation to Behavior Indicative of Trait Anxiety and Depression States

Earnheart, J. C., Schweizer, C., Crestani, F., Iwasato, T., Itohara, S., Mohler, H., & Lüscher, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3609-06.2007 · Cited by 203 · see citing works

Abuse and dependence liability of benzodiazepine-type drugs: GABAA receptor modulation and beyond

Licata, S. C., & Rowlett, J. K. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.01.001 · Cited by 201 · see citing works

A schizophrenia-related sensorimotor deficit links α3-containing GABA _A receptors to a dopamine hyperfunction

Yee, B. K., Keist, R., von Boehmer, L., Studer, R., Benke, D., Hagenbuch, N., Dong, Y., Malenka, R. C., Fritschy, J.-M., Bluethmann, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508752102 · Cited by 201 · see citing works

TPA023 [7-(1,1-Dimethylethyl)-6-(2-ethyl-2 H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an Agonist Selective for α2- and α3-Containing GABAA Receptors, Is a Nonsedating Anxiolytic in Rodents and Primates

Atack, J. R., Wafford, K. A., Tye, S. J., Cook, S. M., Sohal, B., Pike, A., Sur, C., Melillo, D., Bristow, L., Bromidge, F., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.089920 · Cited by 188 · see citing works

Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome

Siarey, R. J., Carlson, E. J., Epstein, C. J., Balbo, A., Rapoport, S. I., & Galdzicki, Z. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00083-0 · Cited by 184 · see citing works

mRNA and Protein Levels for GABAAα4, α5, β1 and GABABR1 Receptors are Altered in Brains from Subjects with Autism

Fatemi, S. H., Reutiman, T. J., Folsom, T. D., Rooney, R. J., Patel, D. H., & Thuras, P. D. (2010) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-009-0924-z · Cited by 182 · see citing works

Memory Deficits Induced by Inflammation Are Regulated by α5-Subunit-Containing GABAA Receptors

Wang, D.-S., Zurek, A. A., Lecker, I., Yu, J., Abramian, A. M., Avramescu, S., Davies, P. A., Moss, S. J., Lu, W.-Y., & Orser, B. A. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.08.022 · Cited by 182 · see citing works

α5GABA A Receptor Activity Sets the Threshold for Long-Term Potentiation and Constrains Hippocampus-Dependent Memory

Martin, L. J., Zurek, A. A., MacDonald, J. F., Roder, J., Jackson, M. F., & Orser, B. A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4209-09.2010 · Cited by 179 · see citing works

Pharmacological treatments that facilitate extinction of fear: Relevance to psychotherapy

Davis, M., Myers, K. M., Chhatwal, J., & Ressler, K. J. (2006) · NeuroRX · doi:10.1016/j.nurx.2005.12.008 · Cited by 174 · see citing works

A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia

Buchanan, R. W., Keefe, R. S. E., Lieberman, J. A., Barch, D. M., Csernansky, J. G., Goff, D. C., Gold, J. M., Green, M. F., Jarskog, L. F., Javitt, D. C., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.052 · Cited by 172 · see citing works

A Novel α5GABAAR-Positive Allosteric Modulator Reverses Hyperactivation of the Dopamine System in the MAM Model of Schizophrenia

Gill, K., Lodge, D., Cook, J., Aras, S., & Grace, A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.76 · Cited by 170 · see citing works

Specific Subtypes of GABA A Receptors Mediate Phasic and Tonic Forms of Inhibition in Hippocampal Pyramidal Neurons

Prenosil, G., Gasser, E. M. S., Rudolph, U., Keist, R., Fritschy, J., & Vogt, K. E. (2006) · Journal of Neurophysiology · doi:10.1152/jn.01199.2005 · Cited by 169 · see citing works

Searching for perfect sleep: the continuing evolution of GABA _A receptor modulators as hypnotics

Nutt, D. J., & Stahl, S. M. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109106927 · Cited by 163 · see citing works

Specific targeting of the GABA-A receptor α5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice

Braudeau, J., Delatour, B., Duchon, A., Pereira, P. L., Dauphinot, L., de Chaumont, F., Olivo‐Marín, J., Dodd, R. H., Hérault, Y., & Potier, M. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111405366 · Cited by 163 · see citing works

RO4938581, a novel cognitive enhancer acting at GABAA α5 subunit-containing receptors

Ballard, T. M., Knoflach, F., Prinssen, E. P. M., Borroni, E., Vivian, J. A., Basile, J., Gasser, R., Moreau, J., Wettstein, J. G., Buettelmann, B., et al. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1357-7 · Cited by 156 · see citing works

Reducing GABA A α5 Receptor-Mediated Inhibition Rescues Functional and Neuromorphological Deficits in a Mouse Model of Down Syndrome

Martínez‐Cué, C., Martinez, P. M., Rueda, N., Vidal, R., García-Cerro, S., Vidal, V., Corrales, A., Montero, J. A., Pazos, Á., Flórez, J., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1203-12.2013 · Cited by 154 · see citing works

Memory Reconsolidation Mediates the Updating of Hippocampal Memory Content

Lee, J. L. C. (2010) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2010.00168 · Cited by 153 · see citing works

Down Syndrome: From Understanding the Neurobiology to Therapy

Gardiner, K., Hérault, Y., Lott, I. T., Antonarakis, S. E., Reeves, R. H., & Dierssen, M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3728-10.2010 · Cited by 149 · see citing works

Benzodiazepines as antidepressants: Does GABA play a role in depression?

Petty, F., Trivedi, M. H., Fulton, M., & Rush, A. J. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00049-7 · Cited by 143 · see citing works

γ-Aminobutyric Acid-Type A Receptor Deficits Cause Hypothalamic-Pituitary-Adrenal Axis Hyperactivity and Antidepressant Drug Sensitivity Reminiscent of Melancholic Forms of Depression

Shen, Q., Lal, R., Luellen, B. A., Earnheart, J. C., Andrews, A. M., & Luscher, B. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.024 · Cited by 139 · see citing works

Molecular regulation of cognitive functions and developmental plasticity: impact of GABAAreceptors

Möhler, H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04454.x · Cited by 137 · see citing works

Distinct mechanisms regulate GABAA receptor and gephyrin clustering at perisomatic and axo‐axonic synapses on CA1 pyramidal cells

Panzanelli, P., Gunn, B. G., Schlatter, M. C., Benke, D., Tyagarajan, S. K., Scheiffele, P., Belelli, D., Lambert, J. J., Rudolph, U., & Fritschy, J. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.216028 · Cited by 136 · see citing works

Pharmacophore/Receptor Models for GABAA/BzR Subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) via a Comprehensive Ligand-Mapping Approach

Huang, Q. Z., He, X., Ma, C., Liu, R., Yu, S., Dayer, C. A., Wenger, G. R., McKernan, R. M., & Cook, J. M. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990341r · Cited by 134 · see citing works

GABAA receptors containing the α5 subunit mediate the trace effect in aversive and appetitive conditioning and extinction of conditioned fear

Yee, B. K., Hauser, J., Dolgov, V. V., Keist, R., Möhler, H., Rudolph, U., & Feldon, J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03642.x · Cited by 132 · see citing works

Synaptic  5 Subunit-Containing GABAA Receptors Mediate IPSPs Elicited by Dendrite-Preferring Cells in Rat Neocortex

Ali, A. B., & Thomson, A. M. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhm160 · Cited by 129 · see citing works

The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: A pilot [11C]Ro15-4513 positron emission tomography study

Méndez, M. A., Horder, J., Myers, J., Coghlan, S., Stokes, P. R. A., Erritzøe, D., Howes, O. D., Lingford-Hughes, A. R., Murphy, D., & Nutt, D. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.04.008 · Cited by 128 · see citing works

Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome

Rueda, N., Flórez, J., & Martínez‐Cué, C. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2007.12.039 · Cited by 127 · see citing works

Training‐induced changes in the expression of GABA_A‐associated genes in the amygdala after the acquisition and extinction of Pavlovian fear

Heldt, S. A., & Ressler, K. J. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05970.x · Cited by 125 · see citing works

Selective anxiolysis produced by ocinaplon, a GABA A receptor modulator

LIPPA, A. S., Czobor, P., Stark, J., Beer, B., Kostakis, E., Gravielle, M. C., Bandyopadhyay, S., Russek, S. J., Gibbs, T. T., Farb, D. H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502579102 · Cited by 125 · see citing works

Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome

Kleschevnikov, A. M., Belichenko, P. V., Gall, J., George, L., Nosheny, R., Maloney, M. T., Salehi, A., & Mobley, W. C. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.10.009 · Cited by 124 · see citing works

Neurosteroid modulation of GABAA receptors: Molecular determinants and significance in health and disease

Mitchell, E. A., Herd, M. B., Gunn, B. G., Lambert, J. J., & Belelli, D. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.10.007 · Cited by 120 · see citing works

Preclinical and clinical pharmacology of the GABAA receptor α5 subtype-selective inverse agonist α5IA

Atack, J. R. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.09.001 · Cited by 116 · see citing works

Imaging the GABA-Benzodiazepine Receptor Subtype Containing the α5-Subunit In Vivo with [ 11 C]Ro15 4513 Positron Emission Tomography

Lingford-Hughes, A. R., Hume, S. P., Feeney, A., Hirani, E., Osman, S., Cunningham, V. J., Pike, V. W., Brooks, D. J., & Nutt, D. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200207000-00013 · Cited by 112 · see citing works

The rise of a new GABA pharmacology

Möhler, H. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.10.020 · Cited by 111 · see citing works

Both α2 and α3 GABAA receptor subtypes mediate the anxiolytic properties of benzodiazepine site ligands in the conditioned emotional response paradigm

Morris, H. V., Dawson, G. R., Reynolds, D. S., Atack, J. R., & Stephens, D. N. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04775.x · Cited by 110 · see citing works

Hippocampal α5 subunit-containing GABAA receptors modulate the expression of prepulse inhibition

Hauser, J., Rudolph, U., Keist, R., Möhler, H., Feldon, J., & Yee, B. K. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001554 · Cited by 109 · see citing works

An Orally Bioavailable, Functionally Selective Inverse Agonist at the Benzodiazepine Site of GABAA α5 Receptors with Cognition Enhancing Properties

Chambers, M. S., Atack, J. R., Carling, R. W., Collinson, N., Cook, S. M., Dawson, G. R., Ferris, P., Hobbs, S. C., O'Connor, D. V., Marshall, G. R., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040863t · Cited by 109 · see citing works

Blockade of alcohol's amnestic activity in humans by an α5 subtype benzodiazepine receptor inverse agonist

Nutt, D., Besson, M. J., Wilson, S. J., Dawson, G. R., & Lingford-Hughes, A. R. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.08.008 · Cited by 109 · see citing works

Functional mapping of GABAA receptor subtypes in the amygdala

Marowsky, A., Fritschy, J., & Vogt, K. E. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03574.x · Cited by 107 · see citing works

Anxioselective anxiolytics: on a quest for the Holy Grail

Skolnick, P. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.08.003 · Cited by 105 · see citing works

The use of cognitive enhancers in animal models of fear extinction.

Kaplan, G. B., & Moore, K. (2011) · Pharmacology, Biochemistry and Behavior · doi:10.1016/j.pbb.2011.01.009 · Cited by 104 · see citing works

Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA A α 2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers

de Haas, S. L., de Visser, S. J., Post, J. P. V. D., Schoemaker, R. C., Dyck, K. V., Murphy, M. G., Smet, M. D., Vessey, L. K., Ramakrishnan, R., Xue, L., et al. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107082108 · Cited by 104 · see citing works

Etomidate Targets α5γ-Aminobutyric Acid Subtype A Receptors to Regulate Synaptic Plasticity and Memory Blockade

Martin, L. J., Oh, G., & Orser, B. A. (2009) · Anesthesiology · doi:10.1097/aln.0b013e3181bbc961 · Cited by 103 · see citing works

Molecular Basis for the GABAA Receptor-Mediated Tonic Inhibition in Rat Somatosensory Cortex

Yamada, J., Furukawa, T., Ueno, S., Yamamoto, S., & Fukuda, A. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhl087 · Cited by 98 · see citing works

Antidepressant-like properties of α2-containing GABAA receptors

Vollenweider, I., Smith, K. S., Keist, R., & Rudolph, U. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.10.009 · Cited by 96 · see citing works

Benzodiazepine-induced anxiolysis and reduction of conditioned fear are mediated by distinct GABAA receptor subtypes in mice

Smith, K. S., Engin, E., Meloni, E. G., & Rudolph, U. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.03.001 · Cited by 94 · see citing works

GABAA Receptor Subtype-Selective Modulators. II. α5-Selective Inverse Agonists for Cognition Enhancement

Atack, J. R. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795371314 · Cited by 85 · see citing works

Relationship between benzodiazepine receptor occupancy and functional effects in vivo of four ligands of differing intrinsic efficacies.

Martin‐Facklam, M., Schoch, P., Bonetti, E. P., Jenck, F., Martin, J. R., Moreau, J., & Haefely, W. E. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11126-9 · Cited by 85 · see citing works

Tonic Inhibition in Principal Cells of the Amygdala: A Central Role for 3 Subunit-Containing GABAA Receptors

Marowsky, A., Rudolph, U., Fritschy, J., & Arand, M. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.4404-11.2012 · Cited by 82 · see citing works

α5 subunit‐containing GABA A receptors affect the dynamic range of mouse hippocampal kainate‐induced gamma frequency oscillations in vitro

Towers, S. K., Gloveli, T., Traub, R. D., Driver, J. E., Engel, D., Fradley, R. L., Rosahl, T. W., Maubach, K. A., Buhl, E., & Whittington, M. A. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.071191 · Cited by 76 · see citing works

Reducing Abuse Liability of GABAA/Benzodiazepine Ligands via Selective Partial Agonist Efficacy at α1 and α2/3 Subtypes

Ator, N. A., Atack, J. R., Hargreaves, R. J., Burns, H. D., & Dawson, G. R. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.158303 · Cited by 66 · see citing works

Preclinical and clinical pharmacology of TPA023B, a GABA A receptor α2/α3 subtype-selective partial agonist

Atack, J. R., Hallett, D. J., Tye, S. J., Wafford, K. A., Ryan, C. N., Bohorquez, S. M. S., Eng, W., Gibson, R., Burns, H. D., Dawson, G., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109354928 · Cited by 63 · see citing works

The discovery and unique pharmacological profile of RO4938581 and RO4882224 as potent and selective GABAA α5 inverse agonists for the treatment of cognitive dysfunction

Knust, H., Achermann, G., Ballard, T. M., Buettelmann, B., Gasser, R., Fischer, H., Hernandez, M., Knoflach, F., Koblet, A., Stadler, H., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.053 · Cited by 63 · see citing works

Anxiogenic-like activity of L-655,708, a selective ligand for the benzodiazepine site of GABAA receptors which contain the alpha-5 subunit, in the elevated plus-maze test

Navarro, J. F., Burón, E., & Martín‐López, M. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00305-6 · Cited by 61 · see citing works

Anxiolytic-like effects of 8-acetylene imidazobenzodiazepines in a rhesus monkey conflict procedure

Fischer, B. D., Licata, S. C., Edwankar, R. V., et al. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.08.011 · Cited by 61 · see citing works

MRK-409 (MK-0343), a GABA A receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans

Atack, J. R., Wafford, K. A., Street, L. O. N. D. O. N. G., Dawson, G., Tye, S. J., Laere, K. V., Bormans, G. M., Bohorquez, S. M. S., Lepeleire, I. D., de Hoon, J., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109354927 · Cited by 60 · see citing works

Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder

Amsterdam, J. D., Kaplan, M. J., Potter, L. S., Bloom, L. H., & Rickels, K. (1986) · Psychopharmacology · doi:10.1007/bf00178511 · Cited by 60 · see citing works

Resolving differences in GABAA receptor mutant mouse studies

Crestani, F., Martin, J. R., Möhler, H., & Rudolph, U. (2000) · Nature Neuroscience · doi:10.1038/80553 · Cited by 59 · see citing works

Contributions of GABA_AReceptor Subtype Selectivity to Abuse Liability and Dependence Potential of Pharmacological Treatments for Anxiety and Sleep Disorders

Ator, N. A. (2005) · CNS Spectrums · doi:10.1017/s1092852900009883 · Cited by 59 · see citing works

Negative modulation of GABAA α5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats

Redrobe, J. P., Elster, L., Frederiksen, K., Bundgaard, C., de Jong, I. E. M., Smith, G. P., Bruun, A. T., Larsen, P. H., & Didriksen, M. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2593-9 · Cited by 57 · see citing works

Mouse Models for Down Syndrome-Associated Developmental Cognitive Disabilities

Liu, C., Belichenko, P. V., Zhang, L., Fu, D., Kleschevnikov, A. M., Baldini, A., Antonarakis, S. E., Mobley, W. C., & Yu, Y. E. (2011) · Developmental Neuroscience · doi:10.1159/000329422 · Cited by 55 · see citing works

A reduction in hippocampal GABA _A receptor α5 subunits disrupts the memory for location of objects in mice

Prut, L., Prenosil, G., Willadt, S., Vogt, K., Fritschy, J. ‐., & Crestani, F. (2010) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2010.00575.x · Cited by 53 · see citing works

Chronic Treatment with a Promnesiant GABA-A -Selective Inverse Agonist Increases Immediate Early Genes Expression during Memory Processing in Mice and Rectifies Their Expression Levels in a Down Syndrome Mouse Model

Braudeau, J., Dauphinot, L., Duchon, A., Loistron, A., Dodd, R. H., Hérault, Y., Delatour, B., & Potier, M. (2011) · Advances in Pharmacological Sciences · doi:10.1155/2011/153218 · Cited by 53 · see citing works

Subtype-Selective GABAA Receptor Modulation Yields a Novel Pharmacological Profile: The Design and Development of TPA023

Atack, J. R. (2009) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)57004-9 · Cited by 52 · see citing works

The Ability of BDNF to Modify Neurogenesis and Depressive-Like Behaviors Is Dependent upon Phosphorylation of Tyrosine Residues 365/367 in the GABAA-Receptor γ2 Subunit

Vithlani, M., Hines, R. M., Zhong, P., Terunuma, M., Hines, D. J., Revilla-Sanchez, R., Jurd, R., Haydon, P. G., Rios, M., Brandon, N. J., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1845-13.2013 · Cited by 51 · see citing works

BindingDB Entry 5122: [3H]RY 80: A high-affinity, selective ligand for gamma-aminobutyric acidA receptors containing alpha-5 subunits.

BindingDB (2012) · PubMed · doi:10.7270/q2pn945p · Cited by 50 · see citing works

The yin and yang of cortical layer 1

Larkum, M. E. (2013) · Nature Neuroscience · doi:10.1038/nn.3317 · Cited by 50 · see citing works

Differential roles of GABAA receptor subtypes in benzodiazepine-induced enhancement of brain-stimulation reward

Reynolds, L. M., Engin, E., Tantillo, G., Lau, H. M., Muschamp, J. W., Carlezon, W. A., & Rudolph, U. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.115 · Cited by 49 · see citing works

GABAA Receptor α Subunits Differentially Contribute to Diazepam Tolerance after Chronic Treatment

Vinkers, C. H., van Oorschot, R., Nielsen, E. Ø., Cook, J. M., Hansen, H. H., Groenink, L., Olivier, B., & Mirza, N. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043054 · Cited by 47 · see citing works

The α1 subunit of the GABA(A) receptor modulates fear learning and plasticity in the lateral amygdala

Wiltgen, B. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.037.2009 · Cited by 47 · see citing works

Hippocampal α5 subunit-containing GABAA receptors are involved in the development of the latent inhibition effect

Gerdjikov, T. V., Rudolph, U., Keist, R., Möhler, H., Feldon, J., & Yee, B. K. (2008) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2007.06.003 · Cited by 43 · see citing works

Reversal of Ketamine-Induced Working Memory Impairments by the GABAAα2/3 Agonist TPA023

Castner, S. A., Arriza, J. L., Roberts, J. C., Mrzljak, L., Christian, E. P., & Williams, G. V. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.01.001 · Cited by 37 · see citing works

Antipsychotic effects of bretazenil, a partial benzodiazepine agonist in acute schizophrenia—A study group report

Delini‐Stula, A., & Berdah-Tordjman, D. (1996) · Journal of Psychiatric Research · doi:10.1016/0022-3956(96)00003-9 · Cited by 35 · see citing works

Diazepam and cocaine potentiate brain stimulation reward in C57BL/6J mice

Straub, C. J., Carlezon, W. A., & Rudolph, U. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.08.025 · Cited by 33 · see citing works

Modulation of α5 Subunit‐Containing GABAA Receptors Alters Alcohol Drinking by Rhesus Monkeys

Rüedi‐Bettschen, D., Rowlett, J. K., Rallapalli, S., Clayton, T., Cook, J. M., & Platt, D. M. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12018 · Cited by 32 · see citing works

Cognitive enhancement by pharmacological and behavioral interventions: the murine Down syndrome model

Möhler, H. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.06.028 · Cited by 30 · see citing works

Discoveries in Down syndrome

Kleschevnikov, A. M., Belichenko, P. V., Salehi, A., & Wu, C. (2012) · Progress in brain research · doi:10.1016/b978-0-444-54299-1.00010-8 · Cited by 29 · see citing works

A Multicenter, Placebo‐Controlled, Double‐Blind, Randomized Study of Efficacy and Safety of Ocinaplon (DOV 273,547) in Generalized Anxiety Disorder

Czobor, P., Skolnick, P., Beer, B., & Lippa, A. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2009.00109.x · Cited by 29 · see citing works

[3H]RY 80: A High-Affinity, Selective Ligand for γ-Aminobutyric AcidA Receptors Containing Alpha-5 Subunits,

Skolnick, P., Hu, R. J., Cook, C. M., et al. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37087-9 · Cited by 24 · see citing works

Role of gamma-aminobutyric acid type A (GABAA) receptor subtypes in acute benzodiazepine physical dependence-like effects: evidence from squirrel monkeys responding under a schedule of food presentation

Fischer, B. D., Teixeira, L. P., Linn, M. L. V., Namjoshi, O. A., Cook, J. M., & Rowlett, J. K. (2013) · Psychopharmacology · doi:10.1007/s00213-013-2975-2 · Cited by 19 · see citing works

Enhancing the function of alpha5-subunit-containing GABAA receptors promotes action potential firing of neocortical neurons during up-states

Drexler, B., Zinser, S., Huang, S., Poe, M. M., Rudolph, U., Cook, J. M., & Antkowiak, B. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.034 · Cited by 17 · see citing works

Stratified medicine in psychiatry: a worrying example or new opportunity in the treatment of anxiety?

Owen, D. R., Rupprecht, R., & Nutt, D. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112443746 · Cited by 17 · see citing works

Eszopiclone facilitation of the antidepressant efficacy of fluoxetine using a social defeat stress model

Brown, R. W., Noel, D. M., Smith, J. J., Smith, M. L., Huggins, K. N., Szebeni, K., Szebeni, A., Duffourc, M. M., Chandley, M., & Ordway, G. A. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.06.013 · Cited by 14 · see citing works

Efficacy and Safety of Zopiclone and Eszopiclone in the Treatment of Primary and Comorbid Insomnia

Najib, J. S. (2010) · Springer eBooks · doi:10.1007/978-3-0346-0226-6_18 · Cited by 9 · see citing works

An emerging circuit pharmacology of GABAA receptors

Engin, E., Benham, R. S., & Rudolph, U. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.04.003 · Cited by 225 · see citing works

Crystal structures of a GABAA-receptor chimera reveal new endogenous neurosteroid-binding sites.

Laverty, D., Thomas, P., Field, M., Andersen, O. J., Gold, M. G., Biggin, P. C., Gielen, M., & Smart, T. G. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3477 · Cited by 179 · see citing works

GABAergic Control of Depression-Related Brain States

Luscher, B., & Fuchs, T. (2015) · Advances in Pharmacology · doi:10.1016/bs.apha.2014.11.003 · Cited by 149 · see citing works

GABAA receptor-acting neurosteroids: a role in the development and regulation of the stress response

Gunn, B. G., Cunningham, L., Mitchell, S. G., Swinny, J. D., Lambert, J. J., & Belelli, D. (2015) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.06.001 · Cited by 149 · see citing works

Early interventions in risk groups for schizophrenia: what are we waiting for?

Sommer, I. E., Bearden, C. E., van Dellen, E., Breetvelt, E. J., Duijff, S. N., Maijer, K., van Amelsvoort, T., de Haan, L., Gur, R. E., Arango, C., et al. (2016) · npj Schizophrenia · doi:10.1038/npjschz.2016.3 · Cited by 140 · see citing works

Autism and Schizophrenia-Associated CYFIP1 Regulates the Balance of Synaptic Excitation and Inhibition

Davenport, E. C., Szulc, B. R., Drew, J., Taylor, J., Morgan, T., Higgs, N. F., López-Doménech, G., & Kittler, J. T. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.092 · Cited by 125 · see citing works

Cryo-EM: the resolution revolution and drug discovery

de Oliveira, T. M., van Beek, L., Shilliday, F., Debreczeni, J. É., & Phillips, C. (2021) · SLAS DISCOVERY · doi:10.1177/2472555220960401 · Cited by 73 · see citing works

The Yin and Yang of GABAergic and Glutamatergic Synaptic Plasticity: Opposites in Balance by Crosstalking Mechanisms

Chapman, C. A., Nuwer, J. L., & Jacob, T. C. (2022) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2022.911020 · Cited by 62 · see citing works

Intergenerational Metabolic Syndrome and Neuronal Network Hyperexcitability in Autism

Rivell, A., & Mattson, M. P. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.08.006 · Cited by 50 · see citing works

Metabolic and psychiatric effects of acyl coenzyme A binding protein (ACBP)/diazepam binding inhibitor (DBI)

Joseph, A., Moriceau, S., Sica, V., Anagnostopoulos, G., Pol, J., Martins, I., Lafarge, A., Maiuri, M. C., Leboyer, M., Loftus, J., et al. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2716-5 · Cited by 44 · see citing works

Repeated nitrous oxide exposure exerts antidepressant-like effects through neuronal nitric oxide synthase activation in the medial prefrontal cortex

Liu, W., Li, Q., Ye, B., Cao, H., Shen, F., Xu, Z., Du, W., Guo, F., Liu, J., Li, T., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00837 · Cited by 24 · see citing works

Formation of GABAA receptor complexes containing α1 and α5 subunits is paralleling a multiple T-maze learning task in mice

Ghafari, M., Falsafi, S. K., Szodorai, E., Kim, E.-J., Li, L., Höger, H., Berger, J., Fuchs, K., Sieghart, W., & Lubec, G. (2017) · Brain Structure and Function · doi:10.1007/s00429-016-1233-x · Cited by 19 · see citing works

Hippocampal GABA A antagonism reverses the novel object recognition deficit in sub-chronic phencyclidine-treated rats

Neugebauer, N. M., Miyauchi, M., Sato, T., Tadano, J., Akal, H., Ardehali, H., & Meltzer, H. Y. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.12.033 · Cited by 7 · see citing works

Do Autism-Specific and General Developmental Screens Have Complementary Clinical Value?

STURNER, R. A., Bergmann, P. E., Howard, B. J., Bet, K., Stewart, L., & Attar, S. M. (2022) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-022-05541-y · Cited by 6 · see citing works

Brief Report: Learning About Autism: Is the Source of Autism Knowledge Associated with Differences in Autism Knowledge, Autism Identity, and Experiences of Stigma

Bury, S., Haschek, A., Wenzel, M., Spoor, J., & Hedley, D. (2022) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-022-05823-5 · Cited by 22 · see citing works

1305 N2O Induces a Leftward Shift in the GABA Response at Recombinant α1 β2 γ2L GABAA Receptors (GABAA R)

Hapfelmeier, G., Haseneder, R., Scheller, M., et al. (1999) · Journal of Neurosurgical Anesthesiology · doi:10.1097/00008506-199910000-00142

Which terms should be used to describe autism? Perspectives from the UK autism community

Kenny, L., Hattersley, C., Molins, B., Buckley, C., Povey, C., & Pellicano, E. (2016) · Autism · doi:10.1177/1362361315588200 · Cited by 1,941 · see citing works

Reporting community involvement in autism research: Findings from the journal Autism

Tan, D. W., Crane, L., Haar, T., Heyworth, M., Poulsen, R., & Pellicano, E. (2025) · Autism · doi:10.1177/13623613241275263 · Cited by 35 · see citing works